LXRX
Lexicon Pharmaceuticals Inc
NASDAQ: LXRX · HEALTHCARE · BIOTECHNOLOGY
$1.61
+3.87% today
Updated 2026-04-30
Market cap
$716.02M
P/E ratio
—
P/S ratio
14.38x
EPS (TTM)
$-0.14
Dividend yield
—
52W range
$1 – $2
Volume
2.4M
Lexicon Pharmaceuticals Inc (LXRX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+56.6%
Last 4 quarters
Revenue YoY growth
-79.3%
Most recent quarter
EPS YoY growth
+55.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-9.4%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-05 | $-0.04 | +40.3% | $1.63 | $1.71 | +4.9% |
| 2025-11-06 | $-0.04 | +42.9% | $1.38 | $1.25 | -9.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.07 | $-0.04 | +40.3% | $5.49M | -79.3% |
| 2025-09-30 | $-0.07 | $-0.04 | +42.9% | $14.18M | +710.4% |
| 2025-06-30 | $-0.09 | $0.01 | +111.1% | $28.87M | +1652.6% |
| 2025-03-31 | $-0.10 | $-0.07 | +32.2% | $1.26M | +11.7% |
| 2024-12-31 | $-0.12 | $-0.09 | +27.9% | $26.55M | +3682.6% |
| 2024-09-30 | $-0.16 | $-0.18 | -12.5% | $1.75M | +980.2% |
| 2024-06-30 | $-0.19 | $-0.17 | +10.5% | $1.65M | +419.6% |
| 2024-03-31 | $-0.20 | $-0.20 | +0.0% | $1.13M | +4608.3% |
| 2023-12-31 | $-0.22 | $-0.20 | +9.1% | $702000.00 | — |
| 2023-09-30 | $-0.21 | $-0.21 | +0.0% | $162000.00 | — |
| 2023-06-30 | $-0.17 | $-0.22 | -29.4% | $317000.00 | — |
| 2023-03-31 | $-0.18 | $-0.17 | +5.6% | $24000.00 | — |
Frequently asked questions
Has Lexicon Pharmaceuticals Inc beaten earnings estimates?
Lexicon Pharmaceuticals Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +56.6% over the last 4 quarters.
How does LXRX stock react to earnings?
LXRX stock has moved an average of -2.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Lexicon Pharmaceuticals Inc's revenue growth rate?
Lexicon Pharmaceuticals Inc reported year-over-year revenue growth of -79.3% in its most recent quarter, with EPS growing +55.6% year-over-year.